TITLE

Correlation between the bronchial subepithelial layer and whole airway wall thickness in patient with asthma

AUTHOR(S)
Kasahara, K.; Shiba, K.; Ozawa, T.; Okuda, K.; Adachi, M.
PUB. DATE
March 2002
SOURCE
Thorax;Mar2002, Vol. 57 Issue 3, p242
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The epithelial reticular basement membrane (Rbm) of the airway wall thickens in patients with asthma. However, whether the thickening parallels whole airway wall thickening, which limits air- flow, is unknown. The aim of this study was to examine the correlation between the bronchial Rbm thickening and whole airway wall thickening in asthma. In addition, the association of Rbm and whole wall thickening with airflow obstruction was examined. Methods: Forty nine patients with asthma and 18 healthy control subjects took part in the study. The Rbm thickness was measured in bronchial biopsy specimens and whole airway wall thickness was assessed with high resolution computed tomographic (HRCT) scanning after pretreatment with oral steroids for 2 weeks and inhaled β2 agonist to minimise reversible changes of the airway walls. The percentage airway wall area (WA%; defined as (wall area/total airway area) × 100) and percentage airway wall thickness (WT%; defined as [(ideal outer diameter - ideal luminal diameter)/ideal outer diameter] × 100) were determined from HRCT scans to assess whole airway wall thickness. Spirometric tests were also performed. Results: WA% and WT% were higher in patients with asthma than in healthy subjects. Both WA% and WT% were strongly correlated with Rbm thickness. Moreover, these three indices of airway wall thickness were inversely correlated with the percentage of predicted forced expiratory volume in 1 second in patients with asthma. Conclusions: These findings indicate that Rbm thickening parallels whole airway wall thickening which can cause irreversible airflow obstruction in patients with asthma.
ACCESSION #
12915255

 

Related Articles

  • Continuing the debate about measuring asthma in population studies. Peat, J. K.; Toelle, B. G.; Marks, G. B.; Mellis, C. M. // Thorax;May2001, Vol. 56 Issue 5, p406 

    The reasons for measuring atopy and airway hyperresponsiveness (AHR) and the methods of validating measurements of in asthma in population studies continue to of be debated. The debate has centred around standards against which to validate asthma measurements but the absence of a "gold standard"...

  • Effects of non-bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine. Vatrella, A.; Parrella, R.; Pelaia, G.; Biscione, G. L.; Tranfa, C. M. E.; de Sarro, G. B.; Bariffi, F.; Marsico, S. A. // European Journal of Clinical Pharmacology;May2001, Vol. 57 Issue 2, p99 

    Objectives: The aim of this study was to evaluate the effects of non-bronchoconstrictive doses of propranolol on airway hyperresponsiveness to methacholine. Methods: Double increasing concentrations (from 0.03 to 64 µg/ml) of inhaled propranolol were administered to a study population which...

  • S100A8/A9 as a Pro-inflammatory Cytokine in Obstructive Airway Disease Via the Multi-Ligand Receptor, RAGE. Halayko, Andrew J.; Sharma, Pawan // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Dec2009, Vol. 8 Issue 4, p306 

    Asthma and chronic obstructive pulmonary disease (COPD) are persistent inflammatory conditions that have exhibited significantly increased prevalence in the past two decades. Though many current medications relieve the symptoms of obstructive airway disease, morbidity can still increase over...

  • Biopharmaceutical Therapeutics for Asthma Remodeling. Das, A. M.; Griswold, D. E.; Torphy, T. J.; Li, L. // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3233 

    Current asthma therapy is aimed at controlling disease symptoms. A subset of asthma patients remains symptomatic despite optimal therapy indicating that an unmet medical need exists for these patients. Innovative therapeutics are needed to treat the unmet need in asthma and biopharmaceutical...

  • Current Animal Models of Bronchial Asthma. Kurucz, I.; Szelenyi, I. // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3175 

    Human asthma is on the rise worldwide. The necessity to develop effective treatments against it requires an organized effort which covers every aspect of the disease from the pathological alterations via the genetic background to the use and development of active remedies. In these processes...

  • PULMONARY FUNCTIONAL INDICES DURING EXERCISE IN HEALTHY AND ASTHMATIC ADULTS. GHANBARZADEH, MOHSEN // Studies in Physical Culture & Tourism;2010, Vol. 17 Issue 1, p21 

    Airway function was assessed from measurements of pulmonary resistance (RL) and forced expiratory vital capacity maneuvers. In asthmatic subjects, forced expiratory volume in 1 sec (FEV1) fell 24 ± 14% and RL increased 176 ± 153% after exercise, whereas normal subjects experienced no...

  • Effects on patients with asthma of eradicating visible indoor mould: a randomised controlled trial. Burr, M. L.; Matthews, I. P.; Arthur, R. A.; Watson, H. L.; Gregory, C. J.; Dunstan, F. D. J.; Palmer, S. R. // Thorax;Sep2007, Vol. 62 Issue 9, p767 

    Background: It is not clear whether associations between respiratory symptoms and indoor mould are causal. A randomised controlled trial was conducted to see whether asthma improves when indoor mould is removed. Methods: Houses of patients with asthma were randomly allocated into two groups. In...

  • The Relationship between Δ-Forced Vital Capacity (Percent Fall in Forced Vital Capacity at the PC20 Dose of Methacholine) and the Maximal Airway Response in Patients Who Have Mild Asthma. Jinho Yu; Young Yoo; Do Kyun Kim; Young Yull Koh // Allergy & Asthma Proceedings;Sep/Oct2005, Vol. 26 Issue 5, p366 

    Airway hypersensitivity is routinely evaluated by measuring the concentration (PC20) of inhaled methacholine or histamine that causes a 20% fall in forced expiratory volume in 1 second (FEV1). It has been suggested that a percentage fall in forced vital capacity (FVC) measured at the PC20 dose...

  • The great expectations of small airways. Bakakos, Petros; Loukides, Stelios; Kostikas, Konstantinos // Pneumon;Jan-Mar2012, Vol. 25 Issue 1, p15 

    The authors explore the role of the small airways in asthma. They discuss the pathophysiology of asthma, the pathological evidence indicating inflammatory and structural changes in the small airways and lung parenchyma of patients with asthma, and the various techniques of assessing small...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics